tiprankstipranks
Advertisement
Advertisement
Acadia Pharmaceuticals price target raised to $36 from $29 at RBC Capital
PremiumThe FlyAcadia Pharmaceuticals price target raised to $36 from $29 at RBC Capital
26d ago
Acadia Pharmaceuticals appoints Carl Segerstorm as CPO
Premium
The Fly
Acadia Pharmaceuticals appoints Carl Segerstorm as CPO
27d ago
Acadia Pharmaceuticals price target raised to $30 from $29 at BofA
Premium
The Fly
Acadia Pharmaceuticals price target raised to $30 from $29 at BofA
1M ago
Acadia Pharmaceuticals price target raised to $35 from $32 at Citi
PremiumThe FlyAcadia Pharmaceuticals price target raised to $35 from $32 at Citi
1M ago
Buy Rating Reiterated on ACADIA as EU Rett Prospects Strengthen; $37 Price Target Unchanged
Premium
Ratings
Buy Rating Reiterated on ACADIA as EU Rett Prospects Strengthen; $37 Price Target Unchanged
1M ago
Acadia Pharmaceuticals rises 13.4%
Premium
The Fly
Acadia Pharmaceuticals rises 13.4%
1M ago
Acadia Shareholders Approve Directors, Executive Pay and Equity Plan
PremiumCompany AnnouncementsAcadia Shareholders Approve Directors, Executive Pay and Equity Plan
2M ago
Acadia Pharmaceuticals price target lowered to $32 from $33 at Citi
Premium
The Fly
Acadia Pharmaceuticals price target lowered to $32 from $33 at Citi
3M ago
ACADIA Pharmaceuticals Signals Confident Path After Q1 Call
Premium
Company Announcements
ACADIA Pharmaceuticals Signals Confident Path After Q1 Call
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100